Suprascapular Nerve Block in Hemiplegic Shoulder Pain - Full Text View

Sponsored by:	Chulalongkorn University
Information provided by:	Chulalongkorn University
ClinicalTrials.gov Identifier:	NCT00732589

Purpose

The purpose of this study is to compare the treatment program of suprascapular nerve block plus physical therapy with therapeutic ultrasound plus physical therapy in stroke patients who have shoulder pain in weak side.

Condition	Intervention	Phase
Shoulder Pain Stroke	Drug: 1% xylocaine Other: ultrasound	Phase II

MedlinePlus related topics: Ultrasound

Drug Information available for: Lidocaine

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Suprascapular Nerve Block Combine Physical Therapy in Hemiplegic Shoulder Pain of Stroke Patients.

Further study details as provided by Chulalongkorn University:

Primary Outcome Measures:

VAS score of pain [ Time Frame: 4 weeks after intervention ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Range of motion of the shoulder joint [ Time Frame: 4 weeks after intervention ] [ Designated as safety issue: No ]

Estimated Enrollment:	0
Study Start Date:	September 2008
Estimated Study Completion Date:	December 2009
Estimated Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
A: Experimental Suprascapular nerve block	Drug: 1% xylocaine 10 cc. of 1%xylocaine, once a week
B: Experimental therapeutic ultrasound	Other: ultrasound ultrasound at shoulder area about 10 mins.

Detailed Description:

Shoulder pain is a common complication after a cerebrovascular accident.Hemiplegic shoulder pain has been shown to affect stroke outcome in a negative way.It interferes with recovery after stroke:it can cause distress and reduced activities and can markedly hinder rehabilitation.Suprascapular nerve block has been shown to be effective as an analgesic for different indications such as shoulder capsulitis.The purpose of this study was to evaluate the effectiveness of this technique conjunction with a rehabilitation program to reduce shoulder pain in hemiplegic patients.

Eligibility

Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Stroke patients who develope shoulder pain at weak limb.
Good conscious and able to access pain score.
No history of drug reaction with xylocaine
No history of fracture,tumor or blood tendency.
Willing to enrolled to study and signs inform consent.

Exclusion Criteria:

Patients who do not meet the inclusion criteria.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00732589

Contacts

Contact: Jariya Boonhong, Physiatist

662-2564433

Jariya_boonhong@yahoo.com

Locations

Thailand
Department of physical medicine and rehabilitation, Faculty of medicien, Chulalongkorn University
Bangkok, Thailand

Sponsors and Collaborators

Chulalongkorn University

Investigators

Principal Investigator:

Jariya Boonhong, physiatist

Unaffiliation

More Information

No publications provided

Responsible Party:	Chulalongkorn University ( Jariya Boonhong/ Department of Rehabilitation Medicine, Faculty of Medicine, Chulalongkorn University )
Study ID Numbers:	Chulalongkorn University, No
Study First Received:	August 8, 2008
Last Updated:	October 30, 2008
ClinicalTrials.gov Identifier:	NCT00732589
Health Authority:	Thailand: Food and Drug Administration

Keywords provided by Chulalongkorn University:

suprascapular nerve block
shoulder pain
hemiplegia

Study placed in the following topic categories:

Hemiplegia
Cerebral Infarction
Shoulder Pain
Joint Diseases
Stroke
Lidocaine
Vascular Diseases

Central Nervous System Diseases
Pain
Brain Diseases
Cerebrovascular Disorders
Signs and Symptoms
Musculoskeletal Diseases
Arthralgia

Additional relevant MeSH terms:

Nervous System Diseases
Physiological Effects of Drugs
Anesthetics
Central Nervous System Depressants
Cardiovascular Agents
Anesthetics, Local
Pharmacologic Actions

Sensory System Agents
Therapeutic Uses
Cardiovascular Diseases
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on February 12, 2009